Logo

EC Clears Thermo Fisher Buy of Phadia

Aug 19, 2011

NEW YORK (GenomeWeb News) – The European Commission has cleared Thermo Fisher Scientific's $3.5 billion purchase of Phadia, the EC said today.

The deal was earlier cleared by the US Federal Trade Commission, and during Thermo Fisher's recent second-quarter earnings conference call, CEO Marc Casper moved up the anticipated close of the transaction to the third quarter from the fourth quarter.

Thermo Fisher said earlier this week it had issued $2.1 billion in senior notes, partly to fund the acquisition.

Filed under

Diagnostics
ABRF
Thermo Fisher Scientific
Breaking News
The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.